Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection

S. Moreno, J. García-Samaniego, A. Moreno, E. Ortega, J. A. Pineda, J. Del Romero, C. Tural, M. A. Von Wichmann, J. Berenguer, Á Castro, R. Espacio

Producció científica: Contribució a revistaArticle de revisióRecercaAvaluat per experts

28 Cites (Scopus)

Resum

Summary. The measurement of fibrosis stage critically affects the identification of the progression of liver disease, the establishment of a prognosis and therapeutic decision making. Liver biopsy has been the single, most useful method to determine the degree of liver fibrosis (LF), but with recognized limitations, mainly associated with its invasiveness. In recent years, alternative noninvasive methods have been developed, including imaging methods, such as transient elastometry, and assays based on serum biomarkers. This article reviews the available studies evaluating the value of various noninvasive methods for the assessment of LF in patients with HIV-infection and HBV/HCV co-infection, and makes recommendations on how to best use and combine them in clinical practice. © 2009 Blackwell Publishing Ltd.
Idioma originalAnglès
Pàgines (de-a)249-258
RevistaJournal of Viral Hepatitis
Volum16
Número4
DOIs
Estat de la publicacióPublicada - 1 d’abr. 2009

Fingerprint

Navegar pels temes de recerca de 'Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection'. Junts formen un fingerprint únic.

Com citar-ho